Columns

Hallucinogen use has increased since 2015, overall and particularly among adults 26 and older, while use decreased in adolescents aged 12–17 years according to a new study by Columbia University Mailman School of Public Health and Columbia University Irving Medical Center.

On Friday, the U.S. House of Representatives gave final approval to historic consumer protection legislation. The Inflation Reduction Act, the official name of the major new law, will give Medicare beneficiaries some pocketbook relief from the relentlessly rising prices of prescription drugs.

As the country prepares for yet another round of COVID-19 boosters this fall, Black and Hispanic populations may be left behind. A new study in Health Affairs finds that while Black and white people had lower rates of uptake for the first dose of a COVID vaccine, Black and Hispanic people were least likely to get a booster shot.

The Treasury Department released new guidelines that will make it easier for state and local governments to apply COVID relief funds to affordable housing projects, reports Joey Garrison at USA Today.

For the first time ever, the U.S. is on the verge of curbing some drug pricing practices that have sparked widespread public anger and generated support for Congressional action.